MedTrace Logo

Prehabilitation in Rectal Cancer: During Neoadjuvant Therapy vs Preoperative

NCT05286086 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2022-03-18

No results posted yet for this study

Summary

Control of the effect of prehabilitation on postoperative morbidity, assessed by the Comprehensive Complication Index (CCI), in patients diagnosed with rectal cancer that will receive neoadjuvant Quimiorradiotherapy (NCRT) and subsequent surgery, performed at the beginning of NCRT or before surgery.

Conditions

  • Rectal Cancer, Adenocarcinoma
  • Chemoradiotherapy

Interventions

BEHAVIORAL

prehabilitation

Control of the physical, nutritional and psychological preparation of the patient who will undergo rectal cancer surgery

Sponsors & Collaborators

  • Corporacion Parc Tauli

    lead OTHER

Principal Investigators

  • Laura Mora, Dr · Parc Tauli University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-31
Primary Completion
2022-03-31
Completion
2025-03-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05286086 on ClinicalTrials.gov